Cargando…

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients

Background: Voriconazole (VCZ) metabolism is influenced by many factors. Identifying independent influencing factors helps optimize VCZ dosing regimens and maintain its trough concentration (C(0)) in the therapeutic window. Methods: We conducted a prospective study investigating independent factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Lin, Liang, Zaiming, Liu, Fang, Lin, Ling, Zhang, Jiao, Xie, Linli, Yu, Mingjie, Sun, Fengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969092/ https://www.ncbi.nlm.nih.gov/pubmed/36860301 http://dx.doi.org/10.3389/fphar.2023.1126580

Ejemplares similares

Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
por: Liang, Zaiming, et al.
Publicado: (2022)

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study
por: Ye, Qinghua, et al.
Publicado: (2022)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
por: Jia, Su-jie, et al.
Publicado: (2021)

The Impact of Plasma Protein Binding Characteristics and Unbound Concentration of Voriconazole on Its Adverse Drug Reactions
por: Yuan, Zi-Qing-Yun, et al.
Publicado: (2020)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide
por: Schulz, Josefine, et al.
Publicado: (2022)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

The effect of inflammation on voriconazole trough concentrations in children
por: ter Avest, Mendy, et al.
Publicado: (2016)

Predicting the Outcome of Voriconazole Individualized Medication Using Integrated Pharmacokinetic/Pharmacodynamic Model
por: Yang, Ping, et al.
Publicado: (2021)

Response of chromoblastomycosis to voriconazole
por: de Lima, Alexandre Moretti, et al.
Publicado: (2016)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

High-Performance Liquid Chromatography for Ultra-Simple Determination of Plasma Voriconazole Concentration
por: Yasu, Takeo, et al.
Publicado: (2022)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)

Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole
por: Udawatte, Nadeeka S., et al.
Publicado: (2020)

Aerosolizable Lipid-Nanovesicles Encapsulating Voriconazole Effectively Permeate Pulmonary Barriers and Target Lung Cells
por: Kaur, Ranjot, et al.
Publicado: (2022)

Interaction and potential mechanisms between atorvastatin and voriconazole, agents used to treat dyslipidemia and fungal infections
por: Xun, Tianrong, et al.
Publicado: (2023)

Invasive trichosporonosis treated with voriconazole
por: Garg, Vaibhav, et al.
Publicado: (2018)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Voriconazole: Hepatotoxicity: case report
Publicado: (2021)

Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022)

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
por: Zhao, Yi‐Chang, et al.
Publicado: (2020)

Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report
por: Liu, Xiaoyan, et al.
Publicado: (2017)

Association of Voriconazole Trough Plasma Concentration with Efficacy and Incidence of Hepatotoxicity in Iranian Patients with Hematological Malignancies
por: Taghvaye-masoumi, Hamidreza, et al.
Publicado: (2021)

Physicochemical data of oleic acid-poloxamer organogel for intravaginal voriconazole delivery
por: Querobino, Samyr M., et al.
Publicado: (2019)

Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
por: Kim, Hannah Yejin, et al.
Publicado: (2020)

Successful treatment of Chrysosporium keratitis with voriconazole
por: Thanathanee, Onsiri, et al.
Publicado: (2017)

Comparison of clinical pharmacology of voriconazole and posaconazole
por: Sienkiewicz, Beata M., et al.
Publicado: (2016)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
por: Shen, Jiquan, et al.
Publicado: (2020)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022)

Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
por: Lin, Qianmeng, et al.
Publicado: (2019)

Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole
por: Teng, Guo-Jie, et al.
Publicado: (2020)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
por: Zhang, Yahui, et al.
Publicado: (2021)

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
por: Zhu, Yingying, et al.
Publicado: (2021)

1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018)

Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2022)

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization
por: Li, SiChan, et al.
Publicado: (2022)

Bacteroides Fragilis Polysaccharide A Ameliorates Abnormal Voriconazole Metabolism Accompanied With the Inhibition of TLR4/NF-κB Pathway
por: Wang, Xiaokang, et al.
Publicado: (2021)

Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study
por: Mushtaq, Mehwish, et al.
Publicado: (2023)

Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans
por: Schulz, Josefine, et al.
Publicado: (2022)

Update on the treatment of disseminated fusariosis: Focus on voriconazole
por: Stanzani, Marta, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_9g6rrk5i198nllmjqp2kecl1e9